Hamilton and bionano genomics announce commercial availability of world's first ultra high molecular weight dna extraction automation solution for ogm

San diego and reno, nev., oct. 26, 2022 (globe newswire) -- hamilton and bionano genomics, inc. (nasdaq: bngo) announced today that the long string vantage, a system for automated, high throughput isolation of ultra high molecular weight (uhmw) dna for use in optical genome mapping (ogm) is commercially available. the long string vantage is the result of collaborative development from the companies and features new and innovative tools and consumables used for consistent, high-quality uhmw dna extraction using human blood samples. the long string vantage is expected to begin shipping in q1 2023.
BNGO Ratings Summary
BNGO Quant Ranking